By examining antigen architectures, MIT researchers built a therapeutic cancer vaccine that may improve tumor response to immune checkpoint blockade treatments.
By sidestepping the need for costly interventions, a new method could potentially reveal gene regulatory programs, paving the way for targeted treatments.
The MIT Human Insight Collaborative will elevate the human-centered disciplines and unite the Institute’s top scholars to help solve the world’s biggest challenges.